Today, we have the privilege of speaking with Ivan Kairatov, a biopharma expert at the forefront of technological innovation in research and development. His work delves into one of the most exciting intersections in modern medicine: the use of artificial intelligence to accelerate the fight
The sudden loss of speech following a stroke can be a profoundly isolating experience, trapping clear thoughts and urgent needs behind a physical inability to articulate them. For many survivors, the mind remains sharp, yet the connection to the muscles of the throat and mouth is severed, leading
Within the dense, jargon-filled lines of a patient's medical chart, the earliest signs of cognitive decline may be hiding in plain sight, often too subtle for even the most diligent clinician to detect during a routine appointment. These faint signals, scattered across years of notes, represent a
Today we're joined by Ivan Kairatov, a Biopharma expert at the forefront of integrating technology and innovation into medical training. We’ll be exploring a groundbreaking initiative that uses ambient AI to transform medical education, moving from sporadic feedback to a model where every clinical
A groundbreaking collaboration is set to address a critical paradox in modern medicine, where potentially life-saving therapies for ultra-rare diseases are abandoned not for lack of scientific merit, but due to insufficient commercial appeal. The American Society of Gene & Cell Therapy (ASGCT) and
Today we sit down with Dr. Ivan Kairatov, a veteran biopharma expert whose work at the intersection of medicinal chemistry and computational biology is pushing the boundaries of treatment for central nervous system disorders. For decades, the neurokinin-1 receptor, or NK1R, was a tantalizing but
